Press Release: The Center for Genomic Interpretation Calls upon Medical Insurers to Cover Confirmatory Testing of 23andMe Customers who are Positive for BRCA1 185delAG, BRCA1 5382insC, or BRCA2 6174delT

23andMe, Inc. recently began reporting three pathogenic variants known to increase a person’s risk for breast and ovarian cancer, among other hereditary cancers. These variants, reported by 23andMe as BRCA1 185delAG, BRCA1 5382insC, and BRCA2 6174delT, are some of the best studied and published pathogenic variants in Hereditary Breast and Ovarian Cancer syndrome. For many [...]

CGI’s Project “High Throughput Whole Exome Genetic Variant Classification” Selected For €100,000 Hello Tomorrow Top 500 Deep-Tech Startup Competition

CGI's project "High Throughput Whole Exome Genetic Variant Classification" has been selected, among more than 3,000 startup projects, as part of Hello Tomorrow’s Top 500 deep-tech startups worldwide. We are excited to attend the Hello Tomorrow Global Summit in Paris on Oct 25-27th with other invited entrepreneurs, innovators, and investors in a competition to win the €100,000 top prize! [...]